Identifying and understanding optical coherence tomography artifacts that may be confused with glaucoma / Identificando e compreendendo os artefatos de tomografia de coerência óptica que podem ser confundidos com o glaucoma

ABSTRACT Optical coherence tomography is often used for detection of glaucoma as well as to monitor progression. This paper reviews the most common types of artifacts on the optical coherence tomography report that may be confused with glaucomatous damage. We mainly focus on anatomy-related artifacts in which the retinal layer segmentation and thickness measurements are correct. In such cases, the probability maps (also known as deviation maps) show abnormal (red and yellow) regions, which may mislead the clinician to assume disease is present. This is due to the anatomic variability of the individual, and the normative database must be taken into account.

RESUMO A tomografia de coerência óptica é frequentemente usada para detectar glaucoma, bem como para monitorar a progressão. Este artigo analisa os tipos mais comuns de artefatos no relatório de tomografia de coerência óptica que podem ser confundidos com danos glaucomatosos. Nós nos concentramos principalmente nos artefatos relacionados à anatomia em que a segmentação da camada da retina e as medidas de espessura estão corretas. Nesses casos, os mapas de probabilidade (também conhecidos como mapas de desvio) mostram regiões anormais (vermelho e amarelo), o que pode induzir o clínico em erro ao supor que a doença está presente. Isto se deve à variabilidade anatômica do indivíduo, e o banco de dados normativo deve ser levado em conta.

Optical coherence tomography angiography findings in patients with ocular and non-ocular Behcet disease / Achados de angiografia por tomografia de coerência óptica em pacientes com doença de Behçet com e sem acometimento ocular

ABSTRACT Purposes: To evaluate the optical coherence tomography angiography findings in patients with Behçet disease with and without ocular involvement. Methods: A total of 40 patients with Behçet disease and 30 healthy controls were enrolled in the study. Retinal vessel density in the superficial capillary plexus and deep capillary plexus, foveal avascular zone area and perimeter, acirculatory index, foveal density, and nonflow area in the superficial retina were automatically measured using the optical coherence tomography angiography software AngioVue and compared between the groups. Results: The mean parafoveal and perifoveal vessel densities in the superficial capillary plexus and deep capillary plexus and foveal density were significantly lower in the eyes with Behçet uveitis compared to the eyes without Behçet uveitis and eyes of the healthy controls. In the eyes with Behçet uveitis, logMAR visual acuity showed a moderate correlation with parafoveal and perifoveal vessel densities and foveal density (r=-0.43, p=0.006; r=-0.62, p<0.001; r=-0.42, p=0.008; respectively). Conclusion: Behçet disease with posterior uveitis was associated with significant perifoveal and parafoveal vascular decrements in the superficial and deep retina.(AU)

RESUMO Objetivo: Avaliar achados de angiografia por tomografia de coerência óptica em pacientes com doença de Behçet com e sem acometimento ocular. Métodos: Foram incluídos 40 pacientes com doença de Behçet e 30 controles saudáveis. A densidade vascular retiniana nos plexos capilares superficial e profundo, a zona avascular foveal, o índice de circularidade, a densidade foveal e a área sem fluxo da retina superficial foram medidos automaticamente, através do software AngioVue para angiografia por tomografia de coerência óptica, e comparados entre os grupos. Resultados: A densidade vascular parafoveal e perifoveal média nos plexos capilares superficial e profundo, bem como a densidade foveal, foram significativamente menores nos olhos com uveíte de Behçet em comparação com os olhos sem uveíte de Behçet e os olhos dos controles saudáveis. Nos olhos com uveíte de Behçet, a acuidade visual logMAR mostrou correlação moderada com a densidade vascular parafoveal e perifoveal e com a densidade foveal (respectivamente, r=-0,43, p=0,006; r=-0,62, p<0,001; e r=-0,42, p = 0,008). Conclusão: A doença de Behçet com uveíte posterior foi associada a decréscimos significativos da vascularização perifoveal e parafoveal na retina superficial e profunda.(AU)

Evaluation of choroidal thickness and retinal nerve fiber layer thickness in patients with unilateral amblyopia: a prospective study / Avaliação da espessura da coroide e da camada de fibras nervosas da retina em pacientes com ambliopia unilateral: um estudo prospectivo

ABSTRACT Purpose: to compare the Subfoveal choroidal thickness (SFCT) and Retinal Nerve Fiber Layer Thickness (RNFL) of amblyopic and normal fellow eyes. Design: Prospective, cross-sectional, observational case series. Methods: Forty patients age 12 to 41 years (mean 23.73 ± 6.42) with unilateral amblyopia were studied. Among them, 11(28.2%) patients had amblyopia secondary to strabismus and 29(71.8 %) had anisometropic amblyopia. Optical coherence tomography (OCT) of the peripapillary RNFL thickness of amblyopic and fellow eyes was performed. RNFL thickness measurements were taken from the superior, inferior, nasal and temporal quadrants in the peripapillary region. Also, subfoveal choroidal thickness (SFCT) was measured using spectral domain optical coherence tomography (SD-OCT). Results: Mean global RNFL thickness of the amblyopic and fellow eyes was 104.48 microns and 102.83 microns, respectively. The difference between the two groups was not statistically significant (p>0.05%). The thicknesses of the superior, inferior, nasal and temporal quadrants of the retinal nerve fiber layer between the amblyopic and normal fellow eyes showed no statistically significant difference (p>0.05%). However, the SFCT of amblyopic eye was 11 or more microns thicker than the fellow eye and this was statistically significant different (p<0.05%). Conclusions: This study demonstrated SFCT in amblyopic eyes was significantly thicker than the normal fellow eyes. The amblyopic process may involve the choroid, but not the prepapillary NFL.

RESUMO Objetivo: comparar a espessura da coroide subfoveal (CSF) e da camada de fibra nervosa retinal (CFNR) de olhos amblíopes e normais. Design: série de casos prospectivos, transversais e observacionais. Métodos: Quarenta pacientes com idade entre 12 e 41 anos (média 23,73 ± 6,42) com ambliopia unilateral foram estudados. Entre eles, 11 (28,2%) pacientes apresentavam ambliopia secundária a estrabismo e 29 (71,8%) apresentavam ambliopia anisometrópica. Foi realizada tomografia de coerência óptica (TCO) da espessura da CFNR peripapilar do olho amblíope e do outro olho. As medidas de espessura da CFNR foram realizadas nos quadrantes superior, inferior, nasal e temporal na região peripapilar. Além disso, a espessura da coroide subfoveal (CSF) foi medida através de tomografia de coerência óptica de domínio espectral (TCO-DE). Resultados: A espessura média global da CFNR do olho amblíope e do outro olho foi de 104,48 mícrons e 102,83 mícrons, respectivamente. A diferença entre os dois grupos não foi estatisticamente significativa (p > 0,05%). As espessuras dos quadrantes superior, inferior, nasal e temporal da camada de fibras nervosas da retina entre o olho amblíope e o normal não apresentaram diferença estatisticamente significativa (p > 0,05%). No entanto, a CSF do olho amblíope foi 11 mícrons mais espessa (ou mais) do que a do outro olho - essa diferença foi estatisticamente significativa (p < 0,05%). Conclusões: Este estudo demonstrou que a CSF dos olhos amblíopes foi significativamente mais espessa do que a dos olhos normais. O processo amblíope pode envolver a coroide, mas ele não envolve a CFNR peripapilar.

Perfil epidemiológico das aplicações intravítreas de Ranibizumab / Epidemiological profile of Ranibizumab intravitreal applications

Resumo Objetivo: O objetivo desse trabalho é avaliar o perfil de aplicações intravítreas do Ranibizumab em uma população de adultos atendidos no Instituto Benjamin Constant, no ano de 2015, levando em consideração o efeito sobre a acuidade visual e a espessura macular após tratamento. O objetivo secundário é apresentar as principais indicações desse tipo tratamento no serviço de olhos acima citado. Métodos: Foi realizado um estudo retrospectivo seccional, em indivíduos acima de 20 anos entre os meses de março a agosto de 2015, para analisar a acuidade visual e espessura foveal pré e pós tratamento. A dose do anti-VEGF utilizada foi de 0,05ml por aplicação com intervalo de quatro semanas entre elas. A aferição da acuidade visual assim como o OCT pós tratamento foram realizados em torno de trinta dias após a última aplicação. As análises estatísticas foram feitas com uso do software SPSS versão 21 e o nível de significância estatística foi de 95% com um valor de p <0,05. Resultado: O estudo mostrou que a principal afecção relacionada a esse tratamento foi a retinopatia diabética não proliferativa associada ao edema macular (32,8%). Após o tratamento indicado com Ranibizumab, houve uma melhora da acuidade visual média de 0,70 para 0,59 (logMAR) e uma regressão da espessura macular, visto no OCT, de 408,1µm para 337,2 µm (valor de p <0,05). Conclusão: Pode-se concluir portanto, que o tratamento com Ranibizumab na população estudada contribuiu para uma melhor qualidade de vida dos pacientes, pois a maioria dele apresentou uma melhora estatisticamente significativa na acuidade visual após as aplicações.

Abstract The objective of this work is to evaluate the profile of intravitreal applications of Ranibizumab in a population of adults attended at the Benjamin Constant Institute in the year of 2015, taking into account the effect on visual acuity and macular thickness after the treatment. The secondary objective is to present the main indications of this type of treatment in the eye care mentioned above. A retrospective cross-sectional study was performed in individuals over 20 years of age between March and August of 2015 to analyze visual acuity and foveal thickness before and after treatment. The dose of anti-VEGF used was 0.05 ml per application with an interval of four weeks between them. Visual acuity assessment as well as OCT post treatment were performed around 30 days after the last application. Statistical analyses were performed using SPSS software version 21 and the level of statistical significance was of 95% with a value of p <0.05. The study showed that the main condition related to this treatment was non-proliferative diabetic retinopathy associated with macular edema (32.8%). After treatment indicated with Ranibizumab, there was an improvement in the average visual acuity from 0.70 to 0.59 (logMAR) and a regression of the macular thickness, seen in the OCT, from 408.1μm to 337.2μm (p < 0.05). It can be concluded, therefore, that treatment with Ranibizumab in the studied population contributed to a better quality of life of the patients, since most of them presented a statistically significant improvement in the visual acuity after the applications.

Evaluation of a birth-related foveal hemorrhage in an infant using optical coherence tomography / Avaliação de uma hemorragia foveal relacionada ao nascimento de uma criança usando tomografia de coerência óptica

ABSTRACT During the routine ophthalmologic examination of a 38-day old female infant, indirect ophthalmoscopy revealed a dense hemorrhage on the fovea and a couple of superficial hemorrhages in the nasal retina of the left eye. No hemorrhage was observed in the right eye. A hand-held spectral domain optical coherence tomography (SD-OCT) was used at the time of diagnosis. The hemorrhage at the nasal retina resolved in the first week of follow-up, and the foveal hemorrhage resolved 12 weeks after birth. Spectral domain optical coherence tomography was repeated once the foveal hemorrhage had resorbed, and it showed that the foveal contour had reformed without any sequelae. This case suggests that birth-related foveal hemorrhages do not cause any disturbance in the foveal architecture.

RESUMO Durante o exame oftalmológico de rotina de uma criança do sexo feminino de 38 dias, a oftalmoscopia indireta revelou uma hemorragia densa na fóvea e algumas hemorragias superficiais na retina nasal do olho esquerdo. Nenhuma hemorragia foi observada no olho direito. Foi utilizada uma tomografia de coerência óptica de domínio espectral no momento do diagnóstico. A hemorragia na retina nasal foi resolvida na primeira semana de acompanhamento e a hemorragia foveal foi resolvida em 12 semanas após o nascimento. A tomografia de coerência óptica de domínio espectral foi repetida uma vez que a hemorragia foveal foi reabsorvida, e mostrou que o contorno foveal havia se reformado sem sequelas. Este caso sugere que as hemorragias foveais relacionadas ao nascimento não causam qualquer distúrbio na arquitetura foveal.

Incidence of anterior segment neovascularization during intravitreal treatment for macular edema secondary to central retinal vein occlusion / Incidência de neovasos de segmento anterior durante o tratamento de edema macular secundário a oclusão da veia central da retina

ABSTRACT Purpose: To analyze the effects of injections of intravitreal triamcinolone acetonide (IVTA) and intravitreal bevacizumab (IVB) on the incidence rates of anterior segment neovascularization (ASN) and neovascular glaucoma (NVG) in patients with macular edema secondary to central retinal vein occlusion (CRVO). Methods: In this prospective, randomized, double-masked, sham-controlled study, 35 patients with macular edema following CRVO were randomized to intravitreal bevacizumab, intravitreal triamcinolone acetonide, or sham injections during the first 6 months of the study. The primary outcome was the incidence rate of ASN at month 6. The secondary outcomes were the mean changes from baseline in best-corrected visual acuity (BCVA) and central foveal thickness (CFT) on optical coherence tomography over time to month 12. Results: ASN developed in 8 (22.86%) eyes, including 5 (62.50%) eyes in the sham group and 3 (37.50%) eyes in the IVTA group, during 12 months of fol low-up (p=0.009). BCVA differed significantly (p<0.05) among the groups only at month 1. CFT did not differ significantly (p<0.05) among the groups over 12 months. NVG required surgery and developed in one eye despite laser treatment. Conclusion: Early treatment with intravitreal antivascular endothelial growth factor therapy decreases the rates of ASN and NVG after CRVO.

RESUMO Objetivo: Analisar as taxas de incidência de neovascularização do segmento anterior (NSA) e de glaucoma neovascular (GNV), em pacientes com edema macular secundário a oclusão de veia central da retina (OVCR), em tratamento com injeções intravítreas de triamcinolona (IVTA) ou bevacizumab (IVB). Métodos: Neste estudo prospectivo, randomizado, duplo mascarado e sham controlado, 35 pacientes com edema macular secundário a OVCR foram randomizados para IVB, IVTA ou para o grupo controle (sham), durante os 6 primeiros meses do estudo. O desfecho primário foi a taxa de incidência de NSA no mês 6. Os desfechos secundários foram alterações médias da acuidade visual corrigida (BCVA) e espessura foveal central (EFC) ao exame de tomografia de coerência óptica, até o mês 12. Resultados: NSA ocorreu em oito (22,86%) olhos, cinco (62,50%) olhos no grupo sham e três (37,50%) olhos no grupo tratado com injeções intravítreas de Triamcinolona, Não houve nenhum caso com NSA no grupo tratado com bevacizumab durante 12 meses de acompanhamento (p=0,009). A BCVA apresentou diferença estatisticamente significante (p<0,05) entre os grupos, somente no mês 1. A EFC não apresentou diferenças estatisticamente significantes (p<0,05) entre os grupos ao longo dos 12 meses. GNV ocorreu em um olho apesar do tratamento com laser e este paciente necessitou de intervenção cirúrgica. Conclusão: O tratamento precoce com injeções intravítreas de Anti VEGF podem diminuir as taxas de neovascularização do segmento anterior e glaucoma neovascular após oclusão de veia central da retina.

Structure-functional correlation using adaptive optics, OCT, and microperimetry in a case of occult macular dystrophy / Correlação de estrutura e função da retina utilizando óptica adaptativa, OCT e microperimetria em um caso de distrofia macular oculta

ABSTRACT We report retinal functional and structural changes of a 40-year-old man diagnosed with occult macular dystrophy. Comprehensive ophthalmological evaluation was performed, followed by spectral-domain optical coherence tomography (SD-OC - Heidelberg) and image acquisition using an adaptive optics (AO) camera (RTX1, Imagine Eyes) for photoreceptor density analysis. Functional tests included full-field ERG (ERG) and multifocal electroretinography (mfERG) (Diagnosys, LLC) and microperimetry with scanning laser ophthalmoscope (SLO) fixation controlled (MAIA, CenterVUE). OCT revealed a line of discontinuity corresponding to cone outer-segment photoreceptors associated with a loss of cone density, highlighted by a dark blue spot on the AO co ne-density map on the fovea in both eyes. Loss of central sensitivity was revealed using microperimetry; ERG was within the normal range, although the mfERG showed a reduced central response amplitude.

RESUMO Relatamos exames de função e estrutura retiniana de paciente masculino, de 40 anos, com diagnóstico clínico de Distrofia Macular Oculta (DMO). Avaliação oftalmológica completa foi seguida por tomografia de Coerência Óptica (SD-OCT - Heidelberg) e exame com câmara de fundo de olho com tecnologia "Adaptive Optics" (AO - RTX1, Imagine Eyes) para análise da densidade de fotorreceptores. Os exames funcionais incluíram: Eletroretinografia de campo total (ERG) e multifocal (mfERG) (Diagnosys - LLC) e microperimetria com controle de fixação (MAIA - CenterVUE). Os exames revelam descontinuidade da camada de fotorreceptores na região central da fóvea em ambos os olhos pelo SD-OCT em associação com perda de densidade no mosaico cones, representado por mancha azulada no mapa do AO. Os exames de função apresentam diminuição da acuidade visual (20/80; 20/50), redução de sensibilidade central na microperimetria. Como esperado, o ERG está dentro da normalidade, mas há redução da amplitude das respostas centrais do mfERG em ambos os olhos.

Angiographically Documented Macular Ischemia after Single Bevacizumab for Macular Edema Secondary to Central Retinal Vein Occlusion

This report describes a case of angiographically documented foveal avascular zone (FAZ) enlargement after a single intravitreal injection of bevacizumab for macular edema secondary to central retinal vein occlusion (CRVO). A 71-year-old female was treated with an intravitreal bevacizumab injection for macular edema following CRVO. Despite successfully decreased edema one month after injection, the postinjection best-corrected visual acuity immediately decreased from 20/40 to 20/1000 (Snellen equivalent). The FAZ area increased from 0.37 mm² to 3.11 mm² (8.4-fold increase). While intravitreal anti-vascular endothelial growth factor is effective and should be considered as a first-line treatment for macular edema secondary to CRVO, it may aggravate macular ischemia.

Experiencia del Implante de Dexametasona Intravítreo para el tratamiento de Edema Macularen Barranquilla, Colombia / Experience with intravitreal dexamethasone implant for macular edema treatment in Barranquilla, Colombia

Objetivos: Mostrar la experiencia y resultados del tratamiento con el implante intravítreo de Dexametasona (Ozurdex) para el edema macular (EM) secundario a patologías vítreo retinianas en una Clínica Oft almológica en Barranquilla - Colombia. Métodos: Reporte de casos retrospectivo, 22 historias clínicas desde el mes de enero del 2012 a mayo del 2016. Se incluyeron datos de pacientes pseudofáquicos con historia clínica de EM secundario a Retinopatía diabética, DMRE húmeda multitratada con Anti VEGF, Oclusión venosa retiniana central (OVCR), uveítis, postoperatorio de cirugía vitreorretiniana por desprendimiento de retina y pelaje de membrana epirretiniana. Las variables registradas fueron edad, sexo, agudeza visual mejor corregida (AVMC), presión intraocular (PIO), subtipo de EM, etiología del EM, respuesta del EM a los 4 meses de tratamiento valorada por OCT. Se utilizó la prueba de T de Wilcoxon para muestras pareadas. Resultados: Edad promedio de 68 años, 61.9% mujeres y 42.86% hombres. En la distribución del EM por OCT de todos los casos en estudio, 54.5% de los casos presentó un EM predominantemente quístico y 45.5% presentó un EM predominantemente difuso. La AVMC de base fue de 0.45 +/- 0.41 logMAR (R: 0 ­ 2 LogMAR) y la AVMC posterior a los 4 meses del tratamiento fue de 0.40 +/- 0.44 logMAR (R: 0 ­ 2 LogMAR, P: 0.476). La PIO presentó picos de elevación durante los meses 1 y 2 posterior al tratamiento en 59.9%, siendo manejada satisfactoriamente con antihipertensivos oculares. Los grosores maculares promedios previos y a los 4 meses del implante fueron de 372.13 µm (R:184 ­ 661 µm) y de 300.18 µm (R: 176 ­ 495 µm) en su grosor foveal central respectivamente. El grupo de EM quístico tuvo una reducción promedio de 121.41 µm (IC 95% 31.07 ­ 211.75, P: 0.013), el grupo de EM difuso tuvo reducción promedia de 13.66 µm (IC 95% -8.94 ­ 36.27, P: 0.201). Conclusiones: Se muestra la experiencia y efectividad del tratamiento con ozurdex intravítreo en el EM asociado a diversas patologías. Se encontró una respuesta con disminución de grosores maculares a 4 meses del tratamiento, con una mayor respuesta por parte del subtipo de EM predominantemente quístico y el EM secundario a OVCR como mejor respondedor de acuerdo a su etiología. Los picos de PIO fueron manejados adecuadamente con antihipertensivos tópicos, no se reportaron otros efectos adversos en la evolución de los pacientes.

Purpose: To show the experience and results of the treatment with intravitreal dexamethasone implant (Ozurdex) for macular edema secondary to vitreous retinal pathologies at an ophthalmologic clinic in Barranquilla, Colombia. Methods: Retrospective case reports study. We reviewed 22 clinical records from January 2012 to May 2016 that met the inclusion criteria. Pseudophakic patients data with clinical history of macular edema (ME) secondary to diabetic retinopathy, wet AMD multitreated with Anti VEGF, Central Retinal Vein Occlusion (CRVO), Uveitis, postoperative vitreoretinal surgery due to retinal detachment and epiretinal membrane peeling were included. The variables recorded were age, sex, best corrected visual acuity (BCVA), intraocular pressure (IOP), subtype of ME, etiology of ME, ME response at 4 months of treatment assessed by OCT. Th e Wilcoxon T test was used for paired samples. Results: Th e average age was 68 years. According to sex there were 61.9% female and 42.86% male. In the distribution of ME by OCT of all the cases under study, 54.5% of the cases had a predominantly cystic ME and 45.5% had a predominantly diff use ME. Th e baseline BCVA was 0.45 +/- 0.41 logMAR (R: 0-2 LogMAR), the BCVA aft er 4 months of treatment was 0.40 +/- 0.44 logMAR (R:0-2 LogMAR, P: 0.476). IOP showed elevation peaks during months 1 and 2 posttreatment in 59.9%, being satisfactorily managed with ocular antihypertensives. The mean macular thickness prior to and at 4 months of Ozurdex was 372.13 µm (R: 184 - 661 µm) and 300.18 µm (R: 176 - 495 µm) at its central foveal thickness, respectively. Th e cystic ME group had a mean reduction of 121.41 µm (95% CI 31.07 - 211.75, P: 0.013); the diff use ME group had a mean reduction of 13.66 µm (95% CI -8.94 - 36.27, P: 0.201). Conclusions: We show our experience and the eff ectiveness of treatment with intravitreal ozurdex in ME associated with various pathologies. We found a response with a decrease in macular thickness at 4 months of treatment, with a higher response by the subtype of a predominantly cystic ME and ME secondary to CRVO as the best responder according to its etiology. IOP peaks were handled adequately with topical antihypertensives, no other adverse eff ects were reported in the evolution of patients.

Choroidal thickness variation in highly myopic eyes during the water drinking test / Variação da espessura de coroide em olhos alto míopes durante o teste de sobrecarga hídrica

ABSTRACT Purpose: To evaluate variations in choroidal thickness (CT) during the water drinking test (WDT) in emmetropic eyes (EE) and highly myopic eyes (ME) using spectral-domain optical coherence tomography (SD-OCT). Methods: Clinical trial performed at a tertiary care hospital comprising 30 randomly selected eyes. The WDT and SD-OCT macular scans were performed 10 and 45 min after water ingestion in 15 myopic and 15 EE of 15 healthy patients in each group. Primary study outcomes were average macular CT measured by SD-OCT and intraocular pressure (IOP) during the WDT. Results: The mean spherical equivalent refraction was 0.15 ± 0.24 D in emmetropic and -7.1 ± 1.75 D in ME (p<0.001). No statistical differences between EE and ME were observed during the WDT response. EE had higher CT compared with ME at the fovea (361.4 ± 55.4 vs 257.9 ± 95.3; p<0.001), 3 mm nasal to the fovea (158.0 ± 71.8 vs 122.5 ± 54.5; p =0.047), and 3 mm temporally to the fovea (310.6 ± 52.4 vs 247.6 ± 90.1; p=0.05). Regarding CT variation, significant differences in foveal CT at 10 min after water ingestion were observed in both EE and ME, with no statistically significant difference observed between groups. A moderate correlation between IOP peak during the WDT and CT was demonstrated in ME (r=0.52; p=0.04). Conclusions: No statistically significant differences in CT variation during the WDT were observed between EE and ME, indicating similar behavior of the choroidal bed during the WDT in both groups. Further, CT was thinner in highly ME, with CT variation unable to explain elevations in IOP observed during the WDT.

RESUMO Objetivo: Avaliar a espessura de coroide (EC) e sua variação durante o teste de sobrecarga hídrica (TSH) em olhos emétropes (EE) e míopes (ME) utilizando a tomografia de coerência óptica Spectral-Domain (SD-OCT). Métodos: Ensaio clinico realizado em um hospital terciário. 30 olhos selecionados randomizadamente, 15 míopes e 15 emétropes de 15 pacientes em cada grupo foram submetidos ao TSH e scans maculares com SD-OCT realizados 10 e 45 minutos após a ingestão de água. Os principais resultados avaliados foram média da EC na região macular pelo SD-OCT e pressão intraocular (PIO) durante o TSH. Resultados: O equivalente esférico médio foi de 0.15 ± 0.24 dioptrias em emétropes e -7,1 ± 1,75 dioptrias nos olhos míopes (p<0,001). Não foram encontradas diferenças estatísticas durante a resposta ao TSH entre EE e ME. EE apresentaram maior EC em comparação com ME, tanto na região foveal (361,4 ± 55,4 vs 257,9 ± 95,3; p<0,001), 3 milímetros nasal à fóvea (158,0 ± 71,8 vs 122,5 ± 54,5; p=0,047) e 3 mm temporal à fóvea (310,6± 52.4 vs 247,6 ± 90,1; p=0,05). Em relação à variação da EC, diferenças estatisticamente significativas foram demonstrados na região foveal, 10 minutos após a ingestão de água em ambos EE e ME, sem diferenças entre os grupos. Moderada correlação entre pico de PIO durante o TSH e EC foi demonstrada em ME ( r=0,52; p=0,04). Conclusão: A diferença na variação da EC provocada pelo TSH não foi estatisticamente diferente entre olhos emétropes e míopes, o que sugere um comportamento semelhante da coroide nestes dois grupos quando submetidos ao TSH. Além disso, a EC é mais fina nos olhos alto míopes, e a variação na EC não explica o aumento da PIO durante o TSH.

Choroidal changes in pre-eclampsia during pregnancy and the postpartum period: comparison with healthy pregnancy / Alterações da coroide na pré-eclâmpsia durante a gravidez e período pós-parto: comparação com a gravidez saudável

ABSTRACT Purpose: To investigate subfoveal choroidal thickness (SFCT) in patients with pre-eclampsia using enhanced depth imaging optical coherence tomography (EDI-OCT). Methods: A sample of 73 pregnant women was studied over 28 weeks of gestation. The sample was divided into two groups: one comprising pre-eclamptic pregnant women (n=32), and the other comprising healthy pregnant women (n=41). The SFCT was determined for all patients using EDI-OCT during pregnancy and at the third month of the postpartum period. Results: The SFCTs in pre-eclamptic pregnant women were 351.97 ± 22.44 and 332.28 ± 20.32 µm during the pregnancy and postpartum periods (p<0.001), respectively, whereas these values in healthy pregnant women were 389.73 ± 49.64 and 329.78 ± 22.36 µm (p<0.001), respectively. During pregnancy SFCT in pre-eclamptic pregnant women was significantly thinner than that in healthy pregnant women (p<0.001). However, there was no statistically significant difference during the postpartum period (p=0.623). Conclusions: The results suggest that SFCT is significantly decreased in pre-eclamptic pregnant women than in healthy pregnant women, despite no statistically significant difference in SFCT existing between the groups during the postpartum period.

RESUMO Objetivo: Investigar espessura subfoveal coroidal (SFCT) em pacientes com pré-eclâmpsia usando imagens de tomografia de coerência óptica de profundidade otimizada (EDI-OCT). Método: Uma amostra de 73 mulheres grávidas foi estudado ao longo de 28 semanas de gestação. A amostra foi dividida em dois grupos: um com mulheres grávidas com pré-eclâmpsia (n=32), o outro com as mulheres grávidas saudáveis (n=41). SFCT foi determinada em todos os pacientes utilizando EDI-OCT durante a gravidez e no terceiro mês do período pós-parto. Resultados: Os SFCTs em gestantes com pré-eclâmpsia foram 351,97 ± 22,44 µm e 332,28 ± 20,32 µm durante o período de gravidez e pós-parto (p<0,001), respectivamente. Estes valores em mulheres grávidas saudáveis foram 389,73 ± 49,64 µm e 329,78 ± 22,36 µm (p<0,001), respectivamente. Durante a gravidez o SFCT foi significantemente mais fino em mulheres com pré-eclâmpsia quando comparado com as mulheres saudáveis (p<0,001). No entanto, não houve diferença estatisticamente significante no período pós-parto (p=0,623). Conclusões: Os resultados sugerem que SFCT é significativamente mais fino em gestantes com pré-eclâmpsia do que nas mulheres grávidas saudáveis, apesar de não haver diferença estatisticamente significativa na SFCT entre os grupos durante o período pós-parto.

Association of cumulative dissipated energy and postoperative foveal thickness among patients with age-related cataract who underwent uncomplicated phacoemulsification

@#<p style="text-align: justify;"><strong>PURPOSE:</strong> Cumulative dissipated energy (CDE) is a phacoemulsification unit parameter designed to monitor the amount of energy delivered during phacoemulsification. Studies have already shown that lower CDE levels have better surgical outcomes, specifically in corneal recovery. However, few literature exists regarding the correlation between CDE and foveal thickness.</p> <p style="text-align: justify;"><strong>METHODS:</strong> In this prospective study, subjects with age-related cataract underwent cataract surgery by phacoemulsification. Central subfield thickness (CST), cube volume (CV), and cube average thickness (CAT) of the macula were measured by spectral-domain optical coherence tomography (OCT) at three separate time-points: preoperative, 1 day, and 14 days after cataract surgery. To determine the correlation between parameters, Pearson's correlation coefficients and degree of association, and coefficient of determination (r2 ) were used.</p> <p style="text-align: justify;"><strong>RESULTS:</strong> One hundred eyes from 93 subjects were analysed. Preoperatively, mean CST was 247.71 ± 21.44 µm, CV was 9.38 ± 0.82 mm3 , and CAT was 262.94 ± 22.15 µm. At 12.42 + 11.05 of mean CDE exposure, the fovea increased in thickness in all measured parameters. The relationship between CDE and the change in foveal thickness values from baseline to postoperative Day 1 and Day 14 were examined. The correlation coefficients obtained for CST, CV, and CAT had low association to CDE. Furthermore, only the correlation coefficients of the difference between baseline and Day 1 of CST, and the difference between baseline and Day 14 observations of CV were significant (0.279 and -0.206, p=0.005 and p=0.040, respectively) but still with a low degree of association.</p> <p style="text-align: justify;"><strong>CONCLUSION:</strong> There is a low, significant, direct association of the difference of CST on Day 1 from baseline with CDE, and a low, significant, indirect association of the difference of CV on Day 14 from baseline with CDE after routine phacoemulsification.</p>

Epiretinal Proliferation Associated with Macular Hole and Intraoperative Perifoveal Crown Phenomenon

PURPOSE: To discuss the unique morphology and origin of epiretinal proliferation associated with macular hole (EPMH) occasionally observed in full-thickness macular hole (FT-MH) or lamellar hole (LH) and to introduce the perifoveal crown phenomenon encountered when removing this unusual proliferative tissue. METHODS: Sixteen patients showing EPMH in spectral domain-optical coherence tomography were selected from 212 patients diagnosed with MH, LH, FT-MH, impending MH, macular pseudohole, or epiretinal membrane between January 2013 and December 2014. Of the 212 patients included for clinical analysis, 33, 23, 11, 7, and 190 exhibited LH, FT-MH, impending MH, macular pseudohole, and epiretinal membrane, respectively. We reviewed visual acuity, macular morphology, and clinical course. Surgical specimens were analyzed histologically. RESULTS: EPMH presented as an amorphous proliferation starting from the defective inner/outer segment (IS/OS) junction covering the inner macula surface. Among the 16 patients with EPMH, 11 underwent vitrectomy, and all exhibited the intraoperative perifoveal crown phenomenon. EPMH tissue was sampled in three patients, one of whom had more tissue removed than intended and showed delayed recovery in visual acuity. Despite hole closure, IS/OS junction integrity was not successfully restored in four of 11 patients. Five patients were followed-up without surgical intervention. Visual acuity slightly decreased in three patients and did not change in one patient, while the remaining patient was lost during follow-up. Among the three perifoveal crown tissues obtained, two were successfully analyzed histologically. Neither tissue showed positivity to synaptophysin or S-100 protein, but one showed positivity to cytokeratin protein immunohistochemical staining. CONCLUSIONS: EPMH exhibited a distinct but common configuration in spectral domain-optical coherence tomography. An epithelial proliferation origin is plausible based on its configuration and histological analysis. Perifoveal crown phenomenon was observed when removing EPMH during vitrectomy.

Optical coherence tomography in patients undergoing cataract surgery / Tomografia de coerência óptica em pacientes submetidos a cirurgia de catarata

ABSTRACTPurpose:To assess the ability of spectral domain optical coherence tomography (SD-OCT) to diagnose macular changes pre- and post-cataract surgery and to identify changes in central foveal thickness (CFT) relative to age, sex, and presence of concomitant ophthalmic pathologies, for a period of 6 months post-surgery.Methods:A prospective study of patients evaluated by SD-OCT within 5 h before surgery at 7, 30, 60, 90, and 180 days post-op, with respect to CFT and presence of maculopathy.Results:Ninety-eight eyes of 98 patients were evaluated, with the following mean results: age = 71.4 years, pre-op VA = 0.27 logMAR, and final VA = 0.73 logMAR. There were 21 eyes in patients with diabetes mellitus (DM) and 10 eyes with age-related macular degeneration (AMD), three with epiretinal membrane, and four with glaucoma. Sixty eyes had no other ophthalmic-related pathologies (NOO), and had a mean pre-op CFT of 222 μm, which progressively increased up to the 60thday post-op, reaching a mean of 227.2 μm. No pseudophakic cystoid macular edema was observed. The mean CFT was statistically significantly different (p<0.001) between NOO and diabetic patients from 30 days post-op. Four eyes presented with preoperative diagnosis of AMD as measured by ophthalmoscopy. After completion of the OCT, which was performed within 5 h before surgery, six additional patients were found to have AMD. Of the 98 total eyes, 10 were diagnosed with maculopathy only by OCT exam. Binocular indirect ophthalmoscopy (BIO) was unable to detect such changes.Conclusion:OCT diagnosed preoperative maculopathies in 21.4% of the patients, and was more effective than BIO (11.2%). OCT showed a progressive increase in CFT in diabetics up to 180 days post-operatively, as well as greater CFT in male patients and patients older than 70 years.

RESUMOObjetivos:Avaliar a capacidade da tomografia ocular de coerência de domínio espectral Spectral Domain-Optical Coherence Tomography (SD-OCT) diagnosticar alterações maculares no pré e pós-operatório da cirurgia de catarata e a variação da espessura foveal central (CFT) de acordo com a idade, sexo, presença ou não de oftalmopatias associadas, pelo período de 6 meses após a cirurgia.Método:Estudo prospectivo com pacientes avaliados pela SD/FD-OCT no pré-operatório (dia da cirurgia) e 7, 30, 60, 90 e 180 dias após, no que se refere à EFC e presença de maculopatia.Resultados:Foram avaliados 98 olhos de 98 pacientes, 35 homens e 63 mulheres. O estudo mostrou a seguintes médias: idade = 71,4 anos, AV pré-operatória = 0,27, AV final = 0,73. Vinte-um olhos eram de pacientes com diabetes mellitus (DM), 10 apresentavam degeneração macular relacionada à idade (AMD), 3 com membrana epirretiniana e 4 tinham glaucoma. Sessenta olhos apresentavam-se normais, ou seja, sem outras oftalmopatias (NOO). Avaliando a EFC do grupo NOO observou-se uma CFT média no pré-operatório de 222 μm, que mostrou um aumento progressivo até o 60o dia de pós-operatório, quando atingiu média de 227,2 μm. Não foi observado edema macular cistóide do pseudofácicos. Ao comparar a diferença entre a CFT média de pacientes NOO e pacientes diabéticos, observou-se que os valores são significativos (p<0,001) a partir do 30º dia de pós-operatório. Quatro olhos apresentaram, pela oftalmoscopia, diagnóstico pré-operatório de DMRI. Após a realização do exame de OCT, horas antes da cirurgia, observou-se que mais 6 pacientes apresentavam AMD. Do total de 98 olhos, 10 tiveram o diagnóstico de maculopatia somente pelo exame de OCT. A oftalmoscopia binocular indireta (BIO) não foi capaz de detectar tais alterações.Conclusão:O OCT diagnosticou doenças maculares pré-operatórias em 21,4% dos pacientes, sendo mais efetivo que a BIO (11,2%). Mostrou um aumento progressivo da CFT em diabéticos até 180 dias de pós-operatório. Detectou que a CFT é maior em pacientes do sexo masculino, e que a CFT dos pacientes com mais de 70 anos é maior que em pacientes mais jovens.

Intravitreal Anti-vascular Endothelial Growth Factor for Newly Diagnosed Symptomatic Polypoidal Choroidal Vasculopathy with Extrafoveal Polyps

PURPOSE: To evaluate the 12-month outcome of anti-vascular endothelial growth factor (VEGF) treatment for extrafoveal polypoidal choroidal vasculopathy (PCV). METHODS: This retrospective observational study included 32 eyes of 32 patients newly diagnosed with extrafoveal PCV (polyps located more than 500 microm from the center of the fovea). Patients were treated with intravitreal ranibizumab, bevacizumab, or both. The best-corrected visual acuity (BCVA) and central foveal thickness (CFT) at diagnosis and at 12 months were compared. Eyes were divided into two groups according to the presence of submacular hemorrhage. The BCVA in each group was compared at baseline and at 12 months. RESULTS: During the 12-month study period, patients received an average of 4.0 +/- 1.1 anti-VEGF injections. The BCVA at baseline, three-month post-diagnosis, and 12-month post-diagnosis was 0.59 +/- 0.40, 0.34 +/- 0.38, and 0.38 +/- 0.38, respectively. The BCVA at 12 months was significantly better than the baseline value (p = 0.002). The CFT at baseline, three-month, and 12-month post-diagnosis was 477.1 +/- 194.2 microm, 214.5 +/- 108.8 microm, and 229.8 +/- 106.1 microm, respectively. The CFT at 12 months was significantly lower than the baseline value (p < 0.001). A significant improvement in BCVA was noted in eyes with and without submacular hemorrhage (n = 13, p = 0.032 and n = 19, p = 0.007, respectively). CONCLUSIONS: Anti-VEGF therapy was beneficial in extrafoveal PCV, regardless of the presence of submacular hemorrhage.

Macular thickness measurements using copernicus spectral domain optical coherence tomography

To provide normal macular thickness measurements using Spectral Domain Optical Coherence Tomography [SDOCT, Copernicus, Optopol Technologies, Zawierci, Poland]. Fifty-eight eyes of 58 healthy subjects were included in this prospective study. All subjects had comprehensive ophthalmic examination including best-corrected visual acuity [BCVA]. All the subjects underwent Copernicus SDOCT. Central foveal thickness [CFT] and photoreceptor layer [PRL] thickness were measured and expressed as mean and standard deviation. Mean retinal thickness for each of the 9 regions defined in the Early Treatment Diabetic Retinopathy Study was reported. The data were compared with published literature in Indians using Stratus and Spectralis OCTs to assess variation in instrument measurements. The mean CFT in the study sample was 173.8 +/- 18.16 microns [131-215 microns] and the mean PRL thickness was 65.48 +/- 4.23 microns [56-74 microns]. No significant difference [p = 0.148] was found between CFT measured automated [179.28 +/- 22 microns] and manually [173.83 +/- 18.1 microns]. CFT was significantly lower in women [167.62 +/- 16.36 microns] compared to men [180.03 +/- 18 microns] [p = 0.008]. Mean retinal thickness reported in this study was significantly different from published literature using Stratus OCT and Spectralis OCT. We report the normal mean retinal thickness in central 1 mm area to be between 138 and 242 microns in Indian population using Copernicus SDOCT. We suggest that different OCT instruments cannot be used interchangeably for the measurement of macular thickness as they vary in segmentation algorithms

Measurement of ocular torsion variation following superior oblique tenectomy / Medida da variação da torção ocular após a tenectomia do oblíquo superior

Purposes: To objectively evaluate the torsional effect of the superior oblique muscle-weakening surgery using the tenectomy technique proposed by Souza-Dias. Methods: The present prospective study included 10 patients (20 eyes) with horizontal strabismus, bilateral superior oblique overaction and A-pattern of 15 to 30 prism diopters who underwent superior oblique tenectomy. Objective assessment of ocular torsion was performed by retinography immediately before and one month after surgery. The amount of ocular torsion was determined by measuring the angle formed by a horizontal line drawn across the geometric center of the optic disc and a second line connecting this point to the fovea. Results: The median preoperative angle was 5.56° in the right eyes and -3.43° in the left eyes. The median postoperative angle was 1.84° in the right eyes and -3.12° in the left eyes. The angle variation was statistically significant in both eyes (p=0.012 and p=0.01, respectively). Conclusion: The present study suggests that superior oblique tenectomy has an extorter effect, decreasing the intorsion detected on overaction of this muscle. .

Objetivo: Avaliar, de forma objetiva, a torção ocular após a tenectomia do oblíquo superior, proposta por Souza-Dias. Métodos: Estudo prospectivo de dez pacientes (20 olhos) com estrabismo horizontal, hiperfunção bilateral dos oblíquos anisotropia em A de 15 a 30 dioptrias prismáticas, submetidos à tenectomia bilateral dos oblíquos superiores. A avaliação objetiva da torção foi realizada com a retinografia antes e após a cirurgia, determinando-se o ângulo de torção formado entre a linha horizontal que passa pelo centro do disco óptico e a linha que passa pelo centro da fóvea. Resultados: A mediana dos ângulos de torção pré-operatória foi de 5,56° nos olhos direitos e de 3,43° nos esquerdos. Após a cirurgia, o ângulo mediano foi de 1,84° nos olhos direitos e de -3,12° nos esquerdos. Em ambos os olhos, a variação absoluta foi estatisticamente significativa (p=0,012/p=0,01). Conclusões: O presente estudo demonstrou que a tenectomia do oblíquo superior tem ação extorsora, reduzindo de forma significante a intorção encontrada nos casos de hiperfunção deste músculo. .

Intravitreal bevacizumab therapy for idiophatic juxtafoveolar retinal telangiectasis associated with serous macular detachment / Tratamento com injeção intravítrea de bevacizumabe para telangiectasia justafoveolar idiopática associada a descolamento seroso macular

The authors describe a 50-year-old woman with group 2 juxtafoveolar retinal telangiectasis and macular detachment treated with a single-dose of intravitreous bevacizumab injection. There was an improvement in her visual acuity, with a decrease in retinal thickness showed by the optical coherence tomography and fluorescein leakage in the angiography on follow-up visits. No adverse events were observed as a result of the treatment used. After one year of follow-up, the vision remained stable and macular detachment did not recur.

Os autores descrevem uma paciente do sexo feminino com 50 anos de idade portadora de telangiectasia justafoveolar idiopática tipo 2, associada a descolamento macular e tratada com injeção intravítrea de bevacizumabe, dose única. Houve uma melhora da acuidade visual com diminuição da espessura retiniana documentada por tomografia de coerência óptica e angiografia fluoresceínica durante seu acompanhamento. Não observou-se efeitos adversos em consequência do tratamento. Após um ano de acompanhamento, sua visão permaneceu estável e o descolamento macular não recorreu.

Optical coherence tomography [OCT]; findings and visual acuity [V/A] in diabetic macular edema [DME] patients

To see the consequences of diabetic macular edema as assessed by optical coherence tomography [OCT] and visual acuity [V/A]. A prospective observational study. Patients were selected by simple random technique. Jan 2012 - Dec 2013. A total of one hundred patients [200 eyes] of ages forty two to sixty three years with an average age of 51.04 +/- 6.26 years of either sex were included. All these patients were examined in the outpatient department and were diagnosed as diabetic with macular edema and no opacity in refractive media. Their V/A was checked. OCT was performed in the Diagnostic and Research Centre, Department of Ophthalmology, Allied Hospital, Faisalabad. Out of 200 eyes on OCT our findings were Diffuse Retinal Thickening in 199 eyes [99.5%], Cystoid Macular Edema in 119 eyes [59.5%], Subretinal Fluid in 48 eyes [24%], Epiretinal Membrane in 15 eyes[7.5%], Vitreomacular Traction in 11 eyes [5.5%] and Taut Posterior Hyaloid Membrane in 4 eyes[2%]. The visual acuity on the right side was 0.29+/-0.19 and on left side it was 0.38+/-0.11. The macular thickness was 437.10+/-82.57 microns on the right side and 414.01+/-69.35 microns on the left side. The best-corrected visual acuity was significantly correlated with central foveal thickness. Our results showed, on the right side, a significant negative correlation [correlation coefficient: -0.355, p<0.01] between them. On the left side, a significant negative correlation [correlation coefficient: -0.362, p<0.01] was recorded

Adult foveomacular vitelliform dystrophy / Distrofia viteliforme foveomacular do adulto

Adult foveomacular vitelliform dystrophy is a rare pathology. Less than 1% of the reported cases display perifoveal capillary permeability. The three-year follow-up period of the case revealed a rare form, which had not yet been documented. The patient was a 40-year-old female with normal visual acuity, and a minor complaint of metamorphopsia on the left eye. Retinography showed a perifoveal yellowish subretinal area OS.Angiography showed perifoveal leakage OS. Follow up showed that, over 3 years, capillary incompetence disappeared and the yellow area underwent alterations, becoming atrophic OS. Angiography also showed hyperfluorescence (windows defect). Towards the end, it resembled the appearance of late stage of Best's Disease...

Distrofia viteliforme foveomacular do adulto é uma patologia rara. Menos de 1% dos casos relatados mostram permeabilidade capilar perifoveal. O acompanhamento de 3 anos deste paciente revelou uma forma rara, ainda pouco documentada. O paciente era uma mulher de 40 anos de idade com acuidade visual normal, mas com queixa de metamorfopsia leve no olho esquerdo. A retinografia mostrou uma área sub-retiniana amarelada, perifoveal, com hiperfluorescência na angiofluoresceinografia. O seguimento mostrou, em 3 anos, que a incompetência capilar desapareceu e que a área, antes amarelada, tornou-se atrófica, com hiperfluorescência na angiografia, lembrando o aspecto tardio da doença de Best...